$ARQT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Arcutis Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Arcutis Biotherapeutics, Inc.. Get notifications about new insider transactions in Arcutis Biotherapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 0.58 | 1,222 | 709 | 178,622 | 177.4 K to 178.6 K (+0.69 %) |
| Oct 06 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Buy | P | 25.00 | 296,000 | 7,400,000 | 902,286 | 606.3 K to 902.3 K (+48.82 %) |
| Oct 06 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Buy | P | 25.00 | 200,000 | 5,000,000 | 4,267,564 | 4.1 M to 4.3 M (+4.92 %) |
| Oct 06 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | P | 25.00 | 296,000 | 7,400,000 | 902,286 | 606.3 K to 902.3 K (+48.82 %) |
| Oct 06 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | P | 25.00 | 200,000 | 5,000,000 | 4,267,564 | 4.1 M to 4.3 M (+4.92 %) |
| Oct 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 390 | 655 | 14,448 | |
| Oct 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 1,810 | 3,041 | 34,581 | |
| Oct 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 25.18 | 390 | 9,821 | 177,400 | 177.8 K to 177.4 K (-0.22 %) |
| Oct 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 390 | 655 | 177,790 | 177.4 K to 177.8 K (+0.22 %) |
| Oct 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 28.18 | 1,810 | 51,008 | 177,400 | 179.2 K to 177.4 K (-1.01 %) |
| Oct 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 1,810 | 3,041 | 179,210 | 177.4 K to 179.2 K (+1.02 %) |
| Oct 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 390 | 655 | 14,448 | |
| Oct 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 1,810 | 3,041 | 34,581 | |
| Oct 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 25.18 | 390 | 9,821 | 177,400 | 177.8 K to 177.4 K (-0.22 %) |
| Oct 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 390 | 655 | 177,790 | 177.4 K to 177.8 K (+0.22 %) |
| Oct 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 28.18 | 1,810 | 51,008 | 177,400 | 179.2 K to 177.4 K (-1.01 %) |
| Oct 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 1,810 | 3,041 | 179,210 | 177.4 K to 179.2 K (+1.02 %) |
| Oct 01 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 3,000 | 5,042 | 155,492 | |
| Oct 01 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 30.00 | 3,000 | 90,000 | 566,928 | 569.9 K to 566.9 K (-0.53 %) |
| Oct 01 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 3,000 | 5,042 | 569,928 | 566.9 K to 569.9 K (+0.53 %) |
| Oct 01 2020 | ARQT | Arcutis Biotherape ... | OSBORNE DAVID W | Chief Technical Off ... | Sell | S | 30.00 | 15,000 | 450,000 | 264,279 | 279.3 K to 264.3 K (-5.37 %) |
| Oct 01 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 500 | 840 | 49,482 | |
| Oct 01 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 1,250 | 37,500 | 98,715 | 100 K to 98.7 K (-1.25 %) |
| Oct 01 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 500 | 15,000 | 23,875 | 24.4 K to 23.9 K (-2.05 %) |
| Oct 01 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 500 | 840 | 24,375 | 23.9 K to 24.4 K (+2.09 %) |
| Sep 16 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 0.58 | 1,222 | 709 | 29,328 | |
| Sep 16 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 0.58 | 1,222 | 709 | 177,400 | 176.2 K to 177.4 K (+0.69 %) |
| Sep 02 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 2,200 | 3,696 | 13,810 | |
| Sep 02 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 24.38 | 2,200 | 53,643 | 176,178 | 178.4 K to 176.2 K (-1.23 %) |
| Sep 02 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 2,200 | 3,696 | 178,378 | 176.2 K to 178.4 K (+1.25 %) |
| Aug 21 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 5,000 | 8,400 | 44,982 | |
| Aug 21 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 5,000 | 8,400 | 176,178 | 171.2 K to 176.2 K (+2.92 %) |
| Aug 19 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 5,076 | 8,528 | 13,667 | |
| Aug 19 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 5,076 | 8,528 | 171,178 | 166.1 K to 171.2 K (+3.06 %) |
| Aug 18 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 0.58 | 6,110 | 3,545 | 30,550 | |
| Aug 18 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 0.58 | 6,110 | 3,545 | 166,102 | 160 K to 166.1 K (+3.82 %) |
| Aug 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 67 | 113 | 37,419 | |
| Aug 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 2,733 | 4,591 | 16,010 | |
| Aug 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 25.63 | 67 | 1,717 | 159,992 | 160.1 K to 160 K (-0.04 %) |
| Aug 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 67 | 113 | 160,059 | 160 K to 160.1 K (+0.04 %) |
| Aug 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 25.63 | 2,733 | 70,047 | 159,992 | 162.7 K to 160 K (-1.68 %) |
| Aug 05 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 2,733 | 4,591 | 162,725 | 160 K to 162.7 K (+1.71 %) |
| Aug 05 2020 | ARQT | Arcutis Biotherape ... | Burnett Patrick | See Remarks | Option Exercise | A | 25.89 | 320,000 | 8,284,800 | 320,000 | |
| Aug 05 2020 | ARQT | Arcutis Biotherape ... | Burnett Patrick | See Remarks | Grant | A | 0.00 | 33,500 | 0 | 33,500 | 0 to 33.5 K |
| Jun 15 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 14,875 | 24,999 | 110,080 | |
| Jun 15 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 14,875 | 24,999 | 123,840 | 109 K to 123.8 K (+13.65 %) |
| May 01 2020 | ARQT | Arcutis Biotherape ... | Gilbert Halley E | Director | Option Exercise | A | 26.00 | 37,500 | 975,000 | 37,500 | |
| Mar 16 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 59,481 | 99,964 | 158,492 | |
| Mar 16 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 59,481 | 99,964 | 566,928 | 507.4 K to 566.9 K (+11.72 %) |
| Mar 16 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Chief Medical Offic ... | Option Exercise | M | 0.58 | 6,110 | 3,545 | 36,660 | |
| Mar 16 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Chief Medical Offic ... | Buy | M | 0.58 | 6,110 | 3,545 | 159,992 | 153.9 K to 160 K (+3.97 %) |
| Mar 04 2020 | ARQT | Arcutis Biotherape ... | Sun Ricky | Director | Option Exercise | A | 27.61 | 24,000 | 662,640 | 24,000 | |
| Mar 04 2020 | ARQT | Arcutis Biotherape ... | Sun Ricky | Director | Option Exercise | A | 27.61 | 24,000 | 662,640 | 24,000 | |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Chief Medical Offic ... | Option Exercise | A | 27.61 | 12,000 | 331,320 | 12,000 | |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Chief Medical Offic ... | Grant | A | 0.00 | 9,000 | 0 | 153,882 | 144.9 K to 153.9 K (+6.21 %) |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | A | 27.61 | 65,000 | 1,794,650 | 65,000 | |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Grant | A | 0.00 | 29,000 | 0 | 507,447 | 478.4 K to 507.4 K (+6.06 %) |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | Turney Patricia A. | Senior VP, Manufact ... | Option Exercise | A | 27.61 | 27,000 | 745,470 | 27,000 | |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | Turney Patricia A. | Senior VP, Manufact ... | Grant | A | 0.00 | 9,000 | 0 | 9,000 | 0 to 9 K |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | A | 27.61 | 12,000 | 331,320 | 12,000 | |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Grant | A | 0.00 | 9,000 | 0 | 108,965 | 100 K to 109 K (+9.00 %) |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 27.61 | 24,000 | 662,640 | 24,000 | |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | OSBORNE DAVID W | Chief Technical Off ... | Option Exercise | A | 27.61 | 12,000 | 331,320 | 12,000 | |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | OSBORNE DAVID W | Chief Technical Off ... | Grant | A | 0.00 | 9,000 | 0 | 279,279 | 270.3 K to 279.3 K (+3.33 %) |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Option Exercise | A | 27.61 | 27,000 | 745,470 | 27,000 | |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Grant | A | 0.00 | 9,000 | 0 | 9,000 | 0 to 9 K |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | Heron Patrick J | Director | Option Exercise | A | 27.61 | 24,000 | 662,640 | 24,000 | |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | ESTES DANIEL | Director | Option Exercise | A | 27.61 | 24,000 | 662,640 | 24,000 | |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Option Exercise | A | 27.61 | 24,000 | 662,640 | 24,000 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Bain Capital Life Sciences Inv ... | 10% Owner | Option Exercise | C | 0.00 | 859,573 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Bain Capital Life Sciences Inv ... | 10% Owner | Option Exercise | C | 0.00 | 2,825,602 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | P | 17.00 | 294,117 | 4,999,989 | 3,979,292 | 3.7 M to 4 M (+7.98 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | C | 0.00 | 859,573 | 0 | 3,685,175 | 2.8 M to 3.7 M (+30.42 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | C | 0.00 | 2,825,602 | 0 | 2,825,602 | 0 to 2.8 M |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Heron Patrick J | Director | Option Exercise | C | 0.00 | 1,074,467 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Heron Patrick J | Director | Option Exercise | C | 0.00 | 2,099,019 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Heron Patrick J | Director | Option Exercise | C | 0.00 | 6,360,272 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Heron Patrick J | Director | Buy | P | 17.00 | 500,000 | 8,500,000 | 10,542,790 | 10 M to 10.5 M (+4.98 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Heron Patrick J | Director | Buy | C | 0.00 | 1,074,467 | 0 | 10,042,790 | 9 M to 10 M (+11.98 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Heron Patrick J | Director | Buy | C | 0.00 | 2,099,019 | 0 | 8,968,323 | 6.9 M to 9 M (+30.56 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Heron Patrick J | Director | Buy | C | 0.00 | 6,360,272 | 0 | 6,869,304 | 509 K to 6.9 M (+1,249.48 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,074,467 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 2,099,019 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 6,360,272 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | P | 17.00 | 500,000 | 8,500,000 | 10,542,790 | 10 M to 10.5 M (+4.98 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 1,074,467 | 0 | 10,042,790 | 9 M to 10 M (+11.98 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 2,099,019 | 0 | 8,968,323 | 6.9 M to 9 M (+30.56 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 6,360,272 | 0 | 6,869,304 | 509 K to 6.9 M (+1,249.48 %) |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 429,786 | 0 | 0 | |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 859,573 | 0 | 0 | |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,825,603 | 0 | 0 | |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 429,786 | 0 | 606,286 | 176.5 K to 606.3 K (+243.50 %) |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 859,573 | 0 | 4,067,564 | 3.2 M to 4.1 M (+26.79 %) |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 2,825,603 | 0 | 3,207,991 | 382.4 K to 3.2 M (+738.94 %) |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Buy | P | 17.00 | 176,500 | 3,000,500 | 176,500 | 0 to 176.5 K |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Buy | P | 17.00 | 382,388 | 6,500,596 | 382,388 | 0 to 382.4 K |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 429,786 | 0 | 0 | |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 859,573 | 0 | 0 | |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 2,825,603 | 0 | 0 | |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 429,786 | 0 | 606,286 | 176.5 K to 606.3 K (+243.50 %) |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 859,573 | 0 | 4,067,564 | 3.2 M to 4.1 M (+26.79 %) |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 2,825,603 | 0 | 3,207,991 | 382.4 K to 3.2 M (+738.94 %) |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | P | 17.00 | 176,500 | 3,000,500 | 176,500 | 0 to 176.5 K |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | P | 17.00 | 382,388 | 6,500,596 | 382,388 | 0 to 382.4 K |
| Feb 03 2020 | ARQT | Arcutis Biotherape ... | TURNER JOSEPH L | Director | Option Exercise | A | 17.00 | 37,500 | 637,500 | 37,500 |